Our in vitro data demonstrated that activation of AT2R on RA-FLS with the selective agonist CGP42112A significantly downregulated the expression of IL1B and IL6 genes, while opposite effects were observed when cells were silenced for AT2R. This evidence concerns the gene IL6 and rheumatoid arthritis.